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Early pioneering work in the field of biochemistry identified phosphorylation as a
crucial post-translational modification of proteins with the ability to both indicate and
arbitrate complex physiological processes. More recent investigations have functionally
linked phosphorylation of extracellular signal-regulated kinase (ERK) to a variety of
neurophysiological mechanisms ranging from acute neurotransmitter action to long-term
gene expression. ERK phosphorylation serves as an intracellular bridging mechanism that
facilitates neuronal communication and plasticity. Drugs of abuse, including alcohol and
opioids, act as artificial yet powerful rewards that impinge upon natural reinforcement
processes critical for survival. The graded progression from initial exposure to addiction
(or substance dependence) is believed to result from drug- and drug context-induced
adaptations in neuronal signaling processes across brain reward and stress circuits
following excessive drug use. In this regard, commonly abused drugs as well as
drug-associated experiences are capable of modifying the phosphorylation of ERK within
central reinforcement systems. In addition, chronic drug and alcohol exposure may drive
ERK-regulated epigenetic and structural alterations that underlie a long-term propensity
for escalating drug use. Under the influence of such a neurobiological vulnerability,
encountering drug-associated cues and contexts can produce subsequent alterations
in ERK signaling that drive relapse to drug and alcohol seeking. Current studies are
determining precisely which molecular and regional ERK phosphorylation-associated
events contribute to the addiction process, as well as which neuroadaptations need to
be targeted in order to return dependent individuals to a healthy state.
Keywords: addiction, amygdala, drug dependence, extracellular signal-regulated kinase, nucleus accumbens,
protein phosphorylation, reward, withdrawal
INTRODUCTION
Drugs of abuse act upon a variety of brain centers to alter
neurotransmission and intracellular signaling cascades. With the
perplexing abundance of drug-induced neuroadaptations, the
question remains which alterations result from simple pharmaco-
logical mechanisms following drug exposure, and which changes
go on to drive the aberrant behavioral mechanisms responsible for
addiction. This dilemma has led to multiple conceptualizations of
the neurophysiological mechanisms underlying the graded tran-
sition to addiction. Some have noted the remarkable persistence
of relapse propensity during periods of attempted abstinence,
characterizing addiction as a disorder of learning and memory
(Kelley, 2004; Hyman, 2005; Hyman et al., 2006). Within this
model, drugs of abuse act as unconditioned stimuli that usurp
brain reinforcement circuitry to focus reward-related pursuits
away from natural or adaptive rewards toward pursuit of the
drug of choice (Kalivas and Volkow, 2005). Such a narrowing of
behavioral repertoire is driven by highly incentivized drug-related
cues and contexts that have been repeatedly paired with drug
experiences (Self and Nestler, 1998; Kalivas and O’brien, 2008).
Others have highlighted the engagement and potentiation of brain
stress (or anti-reward) circuitry that follows particularly exces-
sive or escalated drug intake observed in addicted populations
(Ahmed and Koob, 1998). The gradual transition from limited
drug sampling to compulsive intake may actually represent a sub-
stantial interaction of both within- and between-system neuroad-
aptations across brain reinforcement circuitry that contributes to
the persistence of the addicted phenotype (Edwards and Koob,
2010).
With the overwhelming plasticity that has been observed in
preclinical models of reward and addiction (Edwards and Koob,
2012), neuroscientists have long-searched for the most important
molecular substrates for purposes of disease conceptualization
and therapeutic targeting (Kalivas and Volkow, 2005; Nestler,
2005). In 2007, Girault and colleagues proposed that extracellular
signal-regulated kinase (ERK1/2), specifically the ERK2 isoform,
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acts as an intracellular interface for signaling the intersection of
drug reward and drug-related contextual information (Girault
et al., 2007). Their conceptualization focused on the convergence
of dopamine and glutamate transmission within medium spiny
neurons of the striatum (Valjent et al., 2005; Philibin et al.,
2011), although similar signaling convergences could involve a
variety of neurotransmitters at a number of critical limbic centers
involved in various stages of the addiction process. The two major
ERK isoforms are present in multiple brain regions, yet exhibit
a noticeable rostral-caudal gradient whereby ERK1 levels increase
and ERK2 levels decrease from rostral (frontal cortex ERK1/ERK2
ratio of 0.16) to caudal (pons/medulla ERK1/ERK2 ratio of 1.5)
regions (Ortiz et al., 1995). ERK1/2 activation is predicated on
phosphorylation of neighboring tyrosine and threonine residues
(Robbins et al., 1993) by an upstream ERK kinase (or MEK; Payne
et al., 1991) in response to a wide array of extracellular signals.
Pharmacological inhibition of MEK has implicated central ERK
activity in a range of neurobiological phenomenon, including fear
conditioning (Sananbenesi et al., 2003), affective behavior (Einat
et al., 2003), and central pain processing (Fu et al., 2008; Cao et al.,
2009). Moreover, recent data have implicated ERK phosphoryla-
tion and activity across multiple brain regions throughout various
stages of the addiction timeline. The current review focuses on the
critical role of ERK signaling in producing dependence on alcohol
and opioids, two widely abused substance classes (Substance
Abuse and Mental Health Services Administration, 2008). For an
excellent overview of the role of ERK in cocaine addition, see Lu
et al. (2006).
As to how transient ERK phosphorylation might mediate the
chronic, relapsing disorder of addiction, it has been demonstrated
that ERK/mitogen-activated protein kinase (MAPK) activation
often leads to more stable changes in gene expression via mod-
ification of the post-translational properties of histone proteins
(Day and Sweatt, 2011). Histones are nuclear proteins tightly and
ionically linked with DNA, normally serving to silence gene tran-
scription. Modifications of histone proteins alter their association
with DNA, rendering genetic material more or less accessible to
transcriptional machinery (Cheung et al., 2000). As one example
of this signaling cascade, in striatal neurons, ERK is capable of
activating mitogen- and stress-activated kinase 1 (MSK1), which
phosphorylates histone H3, leading to the induction of the imme-
diate early genes c-Fos and c-Jun (Brami-Cherrier et al., 2007).
Consequently, repeated activation of the ERK cascade by drugs
of abuse or environmental stimuli may promote long-term gene
expression and neuronal plasticity associated with the persistence
of addiction via such epigenetic modifications (Figure 1). In the
following, we provide an overview of the role of ERK activity in
the addiction process, from the initial actions of acute alcohol
and opioid exposure to the effects of cues and contexts that
characterize addiction as a chronic, relapsing disease.
EFFECTS OF ALCOHOL EXPOSURE ON NEURONAL
EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)
PHOSPHORYLATION
The role of the ERK signaling pathway in mediating ethanol
sensitivity has been demonstrated in a variety of species, including
FIGURE 1 | ERK phosphorylation integrates and impacts multiple
levels of intracellular signaling to mediate short- and long-term
neuroplasticity associated with the transition to addicted states.
G protein-coupled receptors (gold) and ion channels (green) represent two
major receptor classes that modify ERK phosphorylation in stress and
reward circuitry following neurotransmitter binding. Active ERK can
translocate to the nucleus to drive addiction-related patterns of gene
expression following the subsequent phosphorylation of transcription
factors (dark blue) and core histones (light blue).
zebrafish (Peng et al., 2009) and drosophila (Corl et al., 2009;
Eddison et al., 2011). For example, ethanol acts through the
ERK pathway to promote the adaptive camouflage response in
zebrafish via corticotropin-releasing factor (CRF; Wagle et al.,
2011). Ethanol impacts ERK/MAPK signaling across multiple
organ systems (Aroor and Shukla, 2004), highlighting the cen-
tral role of alcohol in human health and disease processes
(National Institute on Alcohol Abuse and Alcoholism, 2010).
Soon (15 min) after a 1 g/kg intragastric or intraperitoneal
administration of alcohol to rats, neuronal ERK phosphory-
lation is increased in extended amygdala regions (Ibba et al.,
2009; Thorsell et al., 2013), including the nucleus accumbens,
bed nucleus of the stria terminalis, and central amygdala. This
time point corresponds to peak ethanol (Quertemont et al.,
2003) and dopamine (Melis et al., 2007) levels after admin-
istration of this dose, and also produces a conditioned place
preference (CPP) in male (Bahi, 2013) and female (Torres et al.,
2013) rats. In concert with these acute rewarding effects, Ibba
et al. (2009) blocked ethanol-induced ERK phosphorylation
(1 g/kg, 15 min) with a dopamine D1 receptor antagonist.
The association between the rewarding effects of ethanol and
accumbens dopamine release has also been linked to Ras-GRF2,
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an upstream effector of ERK signaling (Stacey et al., 2012).
Increases in ERK phosphorylation post-alcohol appear to be
maintained for a longer period of time in the amygdala (60–
90 min) vs. accumbens and may mediate the anxiolytic and
discriminative stimulus properties of alcohol exposure (Pandey
et al., 2008; Besheer et al., 2012). In concert with these effects,
Pandey and colleagues have elegantly described a functional
role for a compromised BDNF-ERK-CREB signaling axis in
the amygdala in the promotion of alcohol drinking (Pandey
et al., 2006). They were able to demonstrate a reduction in
ERK phosphorylation following antisense-mediated knockdown
of the neuropeptide BDNF in three primary amygdala nuclei
(basolateral, medial, and central). However, only a reduction of
BDNF/pERK/cAMP response element-binding protein (pCREB)
in the medial and central amygdala led to increased drinking,
possibly as a means to restore functional signaling along this
axis. This study demonstrates the ability of alcohol to alter
nuclear and gene transcription systems downstream of ERK (also
see Hansson et al., 2008). Indeed, Pandey and colleagues have
hypothesized that compromised CREB function in the amyg-
dala engenders an anxiety-like state that encourages drinking,
and this theory has been supported in both rats and mice
(Pandey et al., 2003, 2004, 2005; Zhang et al., 2011). Signal-
ing along this axis has even been shown to mediate structural
plasticity in the central and medial amygdala in response to
alcohol drinking (Pandey et al., 2008). In comparison to reward-
ing doses of alcohol (∼1.0–1.5 g/kg), acute administration of
higher doses (2.5–4.5 g/kg) in rats produce reductions in neuronal
ERK phosphorylation, and this may correspond to the aversive
effects of higher doses (Anderson et al., 2010; Torres et al.,
2013; Zhu et al., 2013) that tend to limit alcohol consumption
in non-dependent drinkers. Interestingly, Hodge and colleagues
reported that a lower dose of a MEK-ERK inhibitor given sys-
temically increased alcohol drinking in mice while higher doses
decreased drinking (Faccidomo et al., 2009), further suggesting
that alcohol preference is directly related to neuronal ERK
levels.
In addition to D1 dopamine receptors, a recent study described
the role of brain peptide signaling, specifically the neuropeptide S
(NPS)/NPS receptor system, in mediating the reinforcing effects
of alcohol via ERK phosphorylation in the central amygdala
(Thorsell et al., 2013). Typically, neuropeptides act through G
protein-coupled receptors to activate several signal transduction
cascades at once. However, Heilig and colleagues took advantage
of the selective NPS receptor antagonist NCGC00185684, which
preferentially blocks ERK phosphorylation over cAMP and cal-
cium signaling. They demonstrated that NCGC00185684 reduced
alcohol drinking and progressive ratio responding (a measure of
motivation) for alcohol in non-dependent animals. Although this
drug did not block reinstatement to alcohol-seeking behavior in
rats, relapse may be more of a concern in dependent subjects
seeking to continue along an abstinence regimen. In this regard,
Ruggeri et al. (2010) found that amygdala NPS receptor expres-
sion is increased in withdrawn, alcohol-dependent rats, wherein
NCGC00185684 might be expected to prove efficacious against
relapse-like behaviors.
NEURONAL EXTRACELLULAR SIGNAL-REGULATED KINASE
(ERK) PHOSPHORYLATION IN THE ALCOHOL-DEPENDENT
STATE
Indeed, mounting evidence suggests that ERK phosphorylation
may play a unique role in alcohol dependence in addition to
its effects in mediating the positive reinforcing effects of acute
alcohol exposure. Importantly, the transition from recreational
alcohol use to dependence is associated with an emergence of
negative motivational symptomatology that promotes excessive
drinking (Hansson et al., 2007; Gilpin and Koob, 2008). Such
a condition is modeled via repeated cycles of alcohol intoxi-
cation and abstinence in rodents (Roberts et al., 1996, 2000),
whereby intermittent exposure both represents the human alco-
holic condition and is thought to expedite alcoholism-related
plasticity (O’Dell et al., 2004; Breese et al., 2005). To measure the
effects of excessive and repeated alcohol exposures on neuronal
ERK phosphorylation, Sanna et al. (2002) employed a model
of alcohol dependence that exposed rats to intermittent cycles
(14 h or alcohol exposure, 10 h of abstinence) of dependence-
inducing alcohol vapor (Gilpin et al., 2008). Chronic (14 d)
vapor exposure reduced pERK levels at the end of the alcohol
exposure period (i.e., at peak blood alcohol levels) in several
brain regions including the accumbens and hippocampus (also
see Roberto et al., 2003). In contrast, withdrawal (7–13 h) from
this regimen significantly elevated ERK phosphorylation in the
amygdala, at a time point commensurate with diminished blood
alcohol levels and elevated operant alcohol self-administration
(Edwards et al., 2012a). This neuroadaptation suggests that ERK-
mediated signaling may mark and mediate plasticity induced
by alcohol withdrawal in addition to the effects produced by
drinking. Withdrawal-induced ERK phosphorylation is also in
line with opponent process theories of drug addiction (Koob and
Le Moal, 2008), whereby brain stress systems are hypothesized
to be recruited and potentiated during abstinence from excessive
drug exposure.
A remaining question is which neurotransmitters contribute
to excessive amygdala ERK phosphorylation during withdrawal
in alcohol-dependent animals. The neurobiological basis for the
negative reinforcement mechanisms important for the develop-
ment and maintenance of alcoholism may include neuroadapta-
tions in central neuropeptide systems associated with stress and
anxiety, including the amygdala CRF system (Timpl et al., 1998;
Shekhar et al., 2005). Indeed, previous studies have demonstrated
the recruitment of CRF in the amygdala as a critical element
driving the excessive ethanol intake observed during both acute
and protracted abstinence (Heilig and Koob, 2007). These studies
implicated enhanced CRF signaling in discrete amygdala nuclei,
including the central (Lack et al., 2005; Funk and Koob, 2007;
Funk et al., 2007) and basolateral (Sommer et al., 2008) nuclei
as neuroanatomical substrates driving ethanol dependence. Inter-
estingly, intracerebroventricular administration of CRF in vivo
increases ERK phosphorylation in the basolateral amygdala, but
not central nucleus (Refojo et al., 2005).
In addition, given the remarkable persistence of the addicted
state, some investigators have sought to focus on neuronal
changes that last well into abstinence. Such a “post-dependent”
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state is associated with a stable elevation of forebrain MAPK
signaling elements, including ERK kinases (Rimondini et al.,
2002). As an extension of their preliminary studies, Heilig and
colleagues (Hansson et al., 2008) sought to understand ERK
cascade responsiveness to alcohol in the post-dependent state.
Interestingly, ethanol-induced activation of MEK/ERK-associated
pathways in the medial amygdala is lost in dependent animals.
Moreover, ERK signaling is potentiated and suppresses the neu-
ronal response to alcohol in the frontal cortex and nucleus accum-
bens. Both of these changes may possibly correspond to tolerance
to the rewarding effects of alcohol in dependence, leading to an
escalation of drinking if relapse occurs.
EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)
MODULATION OF ALCOHOL WITHDRAWAL AND
COMPULSIVE ALCOHOL SEEKING
Cue-induced reinstatement of alcohol seeking activates ERK
phosphorylation in the basolateral amygdala (Radwanska et al.,
2008) and nucleus accumbens shell, and this is dependent on
mGluR5 activation in both regions (Schroeder et al., 2008;
Sinclair et al., 2012). These studies suggest that excessive ERK
activity may correspond with potentiated glutamatergic transmis-
sion in alcohol dependence and relapse (Ron, 2004; Chandler
et al., 2006; Szumlinski et al., 2007; Mason et al., 2009; Holmes
et al., 2013).
ERK signaling would also appear to play a connecting role in
the critical interplay between negative affective states (including
anxiety and stress) and ethanol drinking (De Witte et al., 2003).
Alcohol withdrawal potentiates anxiety-like behavior (Valdez
et al., 2002) and sensitizes contextual fear memories (Bertotto
et al., 2006) that in turn increase alcohol consumption (Bertotto
et al., 2010). Interestingly, fear conditioning potentiates ERK
phosphorylation in the basolateral amygdala during withdrawal
in alcohol dependent animals (Bertotto et al., 2011). This effect
was blocked by administration of MK-801, an antagonist of
NMDA receptor channels, which are known to be dysregulated
in the amygdala of dependent rats (Roberto et al., 2004, 2006).
In a similar investigation, Gilpin and colleagues assessed neuronal
activations patterns by measuring ERK phosphorylation follow-
ing exposure to a discrete context previously paired with trau-
matic stress (bobcat urine), mimicking symptom provocation in
human post-traumatic stress disorder (PTSD) patients (Edwards
et al., 2013). In this study, a subgroup of rats that displayed a per-
sistently high avoidance of trauma-related stimuli also exhibited
a long-lasting post-stress escalation of alcohol drinking. High-
avoidance, high-drinking rats also exhibited greater synchronicity
between the dorsal prefrontal cortex and basolateral amygdala,
as measured by individual within-subject and between-region
correlations in ERK phosphorylation upon re-exposure to the
traumatic stress-paired context. This finding corresponds to the
regional synchronization found in PTSD patients upon symptom
provocation (Gilboa et al., 2004), and may underlie the increased
propensity for alcohol abuse in this population (Engdahl et al.,
1998; Jacobsen et al., 2001). In addition, a heightened proclivity
for high-risk prescription opioid use in PTSD sufferers (Seal
et al., 2012) is one piece of evidence suggesting a common
neurobiological substrate underlying alcohol and opioid use dis-
orders in vulnerable populations.
EFFECTS OF OPIOID EXPOSURE ON NEURONAL
EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)
PHOSPHORYLATION
Endogenous opioids represent one of the body’s primary natural
reward systems and play a central role in health and disease
states (Bodnar, 2013), including drug addiction (Trigo et al.,
2010). Exogenous opioids, ranging from opiate derivatives (e.g.,
morphine) to prescription opioid analgesics (e.g., oxycodone),
interact with opioid receptors in the body to produce effects
ranging from therapeutic to pathological (Shurman et al., 2010).
Similar to alcohol, morphine (5 mg/kg, 20 min pretreatment)
acutely elicits ERK phosphorylation in the rodent extended amyg-
dala through a dopamine D1 receptor-dependent process (Valjent
et al., 2004), while higher doses (10–50 mg/kg) produce no
changes or even decreases in neuronal pERK levels, depending
on brain region (Eitan et al., 2003; Muller and Unterwald, 2004;
Valjent et al., 2004; Moron et al., 2010). In striatal neurons, mu-
opioid receptor activation of the ERK cascade also appears to
require receptor phosphorylation by G protein-coupled receptor
kinase (GRK3) and arrestin3 recruitment (Macey et al., 2006).
The rewarding effects of opioids, including oxycodone (Liu et al.,
2009), are associated with ERK activity in the nucleus accum-
bens (Xu et al., 2012). With repeated exposure, psychomotor
sensitization to morphine requires ERK phosphorylation in stri-
atal D1 neurons (Borgkvist et al., 2008). Interestingly, genetic
deletion of the ERK1 isoform leads to enhanced D1 signaling,
greater phosphorylation of the ERK2 isoform, and potentiation
of morphine reward (Mazzucchelli et al., 2002). In addition to
the ventral striatum, Li et al. (2011) linked morphine reward to
increases in central amygdala ERK phosphorylation downstream
of NMDA receptor activation. A D1 receptor-dependent, ERK
mediated process in the basolateral amygdala was also found
to be required for opioid-related memory formation (Lyons
et al., 2013). Interestingly, Laviolette and colleagues have pro-
vided evidence that opioid reward memory consolidation tran-
sitions from an ERK- and basolateral amygdala-dependent pro-
cess to a CaMKII-dependent mechanism in the prefrontal cortex
(Gholizadeh et al., 2013).
NEURONAL EXTRACELLULAR SIGNAL-REGULATED KINASE
(ERK) PHOSPHORYLATION IN THE OPIOID-DEPENDENT
STATE
Chronic heroin self-administration in rats produces a multitude
of symptoms of dependence including elevated brain reward
thresholds (Kenny et al., 2006) and a marked hyperalgesia that
correlates with heroin intake (Edwards et al., 2012b). With
extended access to heroin self-administration (≥6 h/day), animals
will escalate their intake over time and begin to display signs of
physical withdrawal either spontaneously or following mu-opioid
receptor antagonism (Vendruscolo et al., 2011). Intake escalation
represents a critical Diagnostic and Statistical Manual of Mental
Disorders (DSM) criteria for dependence and is associated with
multiple behavioral and neurochemical adaptations that persist
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or become manifest in protracted abstinence (Edwards and Koob,
2013).
In an attempt to shed light on brain regional neuroadap-
tations in ERK signaling following escalation of heroin self-
administration, Self and colleagues (Edwards et al., 2009)
examined ERK phosphorylation across eleven mesolimbic brain
regions. Interestingly, naltrexone by itself significantly reduced
ERK phosphorylation by 24–30% in heroin-naïve animals in
both the ventral tegmental area and substantia nigra, suggesting
a tonic activation of the ERK signaling cascade via endogenous
mu-opioid receptor stimulation in these regions. This blunting
of the ERK pathway by naltrexone was normalized in heroin
self-administering animals receiving a naltrexone challenge, sug-
gesting a relative potentiation of midbrain ERK signaling in
heroin dependence. These data are in harmony with increases
in total ERK1/2 levels found in the midbrain locus coeruleus
in morphine-dependent rats (Ortiz et al., 1995). In forebrain
regions, increases in pERK in the prefrontal cortex and hip-
pocampus predominated following 24 h withdrawal either in the
presence or absence of a naltrexone challenge. In comparison,
naltrexone-precipitated withdrawal (vs. spontaneous withdrawal)
facilitated greater increases in pERK in the nucleus accumbens
and central amygdala. A similar pattern of accumbens ERK
activation was found in morphine-dependent mice receiving a
naloxone challenge, and did not generalize to the other MAPK-
family members p38MAPK or c-Jun N-terminal kinase (JNK;
Li et al., 2010). Extending these findings, Ciccarelli et al. (2013)
delineated a role for ERK signaling in the regulation of epigenetic
marking during opioid withdrawal. They found that naloxone-
precipitated morphine withdrawal increased histone H3 phos-
phorylation through an ERK-dependent process in the nucleus
accumbens. Such epigenetic changes at the histone level likely
represent stable, long-term alterations in gene expression capacity
(Robison and Nestler, 2011) that may underlie the persistence
of addiction (Maze and Nestler, 2011). Recruitment of ERK
signaling in the central amygdala was also found in morphine-
dependent mice (Hofford et al., 2009). The central amygdala is
critically involved in the expression of dysphoria and hyperalgesia
that occurs during opioid dependence, a phenomenon mediated
by CRF signaling (Heinrichs et al., 1995; McNally and Akil,
2002). Potentiated ERK signaling may enhance central amyg-
dala CRF levels via CREB activity, which is increased in CRF
neurons in morphine-dependent animals (Shaw-Lutchman et al.,
2002).
EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK)
SIGNALING IN THE CONTEXT OF OPIOID WITHDRAWAL AND
RELAPSE BEHAVIORS
Opioid withdrawal produces a long-lasting conditioned place
aversion (CPA) in dependent animals (Stinus et al., 2000), indica-
tive of the negative motivational state made manifest following
dependence induction (Koob and Le Moal, 2008). Wang et al.
(2012) recently demonstrated the importance of ERK-mediated
epigenetic regulation within the ventromedial prefrontal cortex
(vmPFC) in the extinction of aversive memories within the
context of morphine withdrawal. In this study, re-exposure to
a withdrawal-paired context elicited ERK phosphorylation and
histone H3 acetylation in the vmPFC, while MEK-ERK inhibition
prevented both induction of H3 acetylation and extinction of
CPA. Thus, disruption of vmPFC ERK signaling may play a role in
opioid craving and relapse under aversive conditions. In concert
with this hypothesis, reduced levels of mu-opioid receptors and
ERK signaling components were found in the prefrontal cortex
of humans who suffered an opioid overdose (Ferrer-Alcón et al.,
2004a,b).
A heightened propensity to relapse is one hallmark of opi-
oid addiction that persists well into abstinence and is typically
preceded by re-exposure to drug-associated cues and contexts
(O’Brien, 1997). The motivating properties of such contextual
cues to elicit relapse-like behavior has been modeled in rodents
(Neisewander et al., 2000; Grimm et al., 2001), whereby alcohol
(Bienkowski et al., 2004) and drug seeking actually increases with
time in the abstinent state. For example, Shaham and colleagues
demonstrated withdrawal time-dependent increases in baseline
heroin seeking as well as footshock stress-induced reinstatement
of heroin seeking (Shalev et al., 2001). This phenomenon has
also been observed in classical (Pavlovian) conditioning models
such as CPP. Expression of morphine CPP gradually increases
over 2 weeks after the last drug-environment pairing (Li et al.,
2008). Interestingly, re-exposure of animals to the morphine-
paired environment at the latest withdrawal time point (14 days)
increased ERK phosphorylation in the central but not basolat-
eral amygdala. This was matched by similar increases in CREB
phosphorylation, providing additional evidence linking this sig-
naling axis in drug reward and addiction liability. Further, inhi-
bition of central amygdala MEK-ERK activity with U0126 also
prevented the expression of the magnified CPP in protracted
abstinence.
CONCLUSION AND FUTURE CHALLENGES
Valjent et al. (2004) hypothesized that a strong activation of pERK
across all three extended amygdala regions distinguishes drugs
most likely to be abused from other psychoactive substances that
are not considered to produce addiction (e.g., antidepressants,
antipsychotics), in accordance with the suggested central role of
these regions in dependence (Koob et al., 2014). Such a molecular
litmus test may be useful to screen the potential addiction liability
of trending recreational substances to complement traditional
behavioral assays (Huang et al., 2012; Aarde et al., 2013). On a
similar note, it is important to mention that the effect of ERK
signaling in mediating compulsive drug seeking may generalize
to natural rewards as well. Grimm et al. (2002, 2005) found that
operant seeking of sucrose increases with withdrawal time, similar
to artificial rewards. Following 3 weeks withdrawal, both cocaine-
and sucrose-seeking behavior elicit striatal ERK phosphorylation,
while only cocaine seeking increases protein kinase A (PKA)
phosphorylation of AMPA GluR1 subunits (Edwards et al., 2011).
Given the role of striatal endogenous opioids in signaling food
palatability (Kelley et al., 2002), ERK activity in central reinforce-
ment systems may play a critical neurobiological role in the global
obesity epidemic (Potenza, 2014). With the extensive overlap in
the neural circuitry engaged by both drug and food cues (Kelley
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et al., 2005; Volkow et al., 2013), further studies into the shared
role of ERK signaling in addiction and obesity are warranted.
Ultimately, neuroscientists hope to produce medical break-
throughs from the basic science knowledge gleaned from a better
understanding of altered ERK signaling in disease processes. Upon
initial examination, the demonstrated role of ERK phosphoryla-
tion in mediating drug and alcohol dependence makes MEK/ERK
blockade an attractive therapeutic strategy. Unfortunately, the
ubiquity of MAPK/ERK activity in virtually all physiological
processes makes systemic inhibition more poison than therapy
(Balmanno and Cook, 2009). However, as discussed above in the
study of Thorsell et al. (2013), directed activation or blockade
of ERK signaling via target receptor ligands that are capable of
selectively influencing this pathway represent one solution to this
dilemma. In addition to NPS receptors, other promising targets of
interest couple to ERK pathways, including CRF1 receptors (Punn
et al., 2006; Kageyama et al., 2007; Hauger et al., 2009; Meng et al.,
2011). In addition, Bruchas and Chavkin (2010) have proposed
that targeting ligand-directed signaling at kappa-opioid receptors
(KORs) may prove useful in the treatment of pain and addiction
by selectively altering distinct members of the MAPK family
(ERK, p38, and JNK). For example, while arrestin-dependent
p38 MAPK activation appears to mediate aversion in animals,
recruitment of JNK signaling in the absence of arrestin results in
an inactivation of KOR activity. The same group demonstrated
that repeated forced swim stress induces striatal ERK phospho-
rylation (Bruchas et al., 2008), similar to heroin withdrawal
(Edwards et al., 2009). Stress-induced ERK activation was blocked
by the long-lasting KOR antagonist norbinaltorphimine, a drug
that has also been demonstrated to block escalation of heroin
self-administration in rodents when injected systemically or into
the ventral striatum (Schlosburg et al., 2013). These remarkable
findings have propelled the design and development of new small
molecule, functionally selective KOR antagonists (Zhou et al.,
2013) that may prove efficacious in managing the hedonic dys-
regulation associated with drug and alcohol dependence (Koob
and Le Moal, 1997; Kenny et al., 2006; Potter et al., 2011; Walker
et al., 2012).
Finally, it will be critical to understand how ERK signaling
interfaces with the multitude of other molecular signaling pro-
cesses influenced by alcohol and opioids, ranging from classical
kinase pathways to systemic inflammatory responses (Crews et al.,
2011; Ting and Van Der Kooy, 2012; Ron and Messing, 2013).
In addition, the interactive nature of and co-dependence on
alcohol and opioids is a subject that has not been investigated
at the level of neuronal ERK signaling. Alcohol and opioids
activate a shared subset of neurobiological systems (Koob and
Bloom, 1988; Herz, 1997; Koob et al., 2003; Siggins et al., 2003;
Gianoulakis, 2009) and exhibit substantial similarity in terms of
withdrawal symptomatology (West and Gossop, 1994; Edwards
et al., 2012b). Thus, it is not surprising that existing studies have
revealed a parallel recruitment of ERK signaling within stress
and reward circuitry across important stages of the addiction
timeline. The addiction field is currently challenged with the task
of translating this basic knowledge at the signal transduction
level into more effective treatments to curb excessive opioid
and alcohol use. Continuing collaboration between addiction
scientists and clinicians in the context of an important functional
integration of addiction-related research aims at the National
Institutes of Health is expected to drive these efforts in the coming
decades.
AUTHORS AND CONTRIBUTORS
Eva R. Zamora-Martinez and Scott Edwards contributed to the
conceptualization and writing of this review.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grant
AA020839 from the National Institute on Alcohol Abuse and
Alcoholism (to Scott Edwards).
REFERENCES
Aarde, S. M., Angrish, D., Barlow, D. J., Wright, M. J. Jr., Vandewater, S. A.,
Creehan, K. M., et al. (2013). Mephedrone (4-methylmethcathinone) supports
intravenous self-administration in Sprague-Dawley and Wistar rats. Addict. Biol.
18, 786–799. doi: 10.1111/adb.12038
Ahmed, S. H., and Koob, G. F. (1998). Transition from moderate to excessive drug
intake: change in hedonic set point. Science 282, 298–300. doi: 10.1126/science.
282.5387.298
Anderson, R. I., Varlinskaya, E. I., and Spear, L. P. (2010). Ethanol-induced
conditioned taste aversion in male sprague-dawley rats: impact of age and stress.
Alcohol. Clin. Exp. Res. 34, 2106–2115. doi: 10.1111/j.1530-0277.2010.01307.x
Aroor, A. R., and Shukla, S. D. (2004). MAP kinase signaling in diverse effects of
ethanol. Life Sci. 74, 2339–2364. doi: 10.1016/j.lfs.2003.11.001
Bahi, A. (2013). Viral-mediated knockdown of mGluR7 in the nucleus accumbens
mediates excessive alcohol drinking and increased ethanol-elicited conditioned
place preference in rats. Neuropsychopharmacology 38, 2109–2119. doi: 10.
1038/npp.2012.122
Balmanno, K., and Cook, S. J. (2009). Tumour cell survival signalling by the ERK1/2
pathway. Cell Death Differ. 16, 368–377. doi: 10.1038/cdd.2008.148
Bertotto, M. E., Bussolino, D. F., Molina, V. A., and Martijena, I. D. (2010).
Increased voluntary ethanol consumption and c-Fos expression in selected
brain areas induced by fear memory retrieval in ethanol withdrawn rats. Eur.
Neuropsychopharmacol. 20, 568–581. doi: 10.1016/j.euroneuro.2010.02.014
Bertotto, M. E., Bustos, S. G., Molina, V. A., and Martijena, I. D. (2006). Influence of
ethanol withdrawal on fear memory: effect of D-cycloserine. Neuroscience 142,
979–990. doi: 10.1016/j.neuroscience.2006.07.013
Bertotto, M. E., Maldonado, N. M., Bignante, E. A., Gorosito, S. V., Cambiasso,
M. J., Molina, V. A., et al. (2011). ERK activation in the amygdala and hip-
pocampus induced by fear conditioning in ethanol withdrawn rats: modulation
by MK-801. Eur. Neuropsychopharmacol. 21, 892–904. doi: 10.1016/j.euroneuro.
2011.01.001
Besheer, J., Fisher, K. R., Cannady, R., Grondin, J. J., and Hodge, C. W. (2012).
Intra-amygdala inhibition of ERK(1/2) potentiates the discriminative stimulus
effects of alcohol. Behav. Brain Res. 228, 398–405. doi: 10.1016/j.bbr.2011.12.023
Bienkowski, P., Rogowski, A., Korkosz, A., Mierzejewski, P., Radwanska, K., Kacz-
marek, L., et al. (2004). Time-dependent changes in alcohol-seeking behaviour
during abstinence. Eur. Neuropsychopharmacol. 14, 355–360. doi: 10.1016/j.
euroneuro.2003.10.005
Bodnar, R. J. (2013). Endogenous opiates and behavior: 2012. Peptides 50, 55–95.
doi: 10.1016/j.peptides.2013.10.001
Borgkvist, A., Valjent, E., Santini, E., Herve, D., Girault, J. A., and Fisone, G.
(2008). Delayed, context- and dopamine D1 receptor-dependent activation of
ERK in morphine-sensitized mice. Neuropharmacology 55, 230–237. doi: 10.
1016/j.neuropharm.2008.05.028
Brami-Cherrier, K., Lavaur, J., Pages, C., Arthur, J. S., and Caboche, J. (2007).
Glutamate induces histone H3 phosphorylation but not acetylation in striatal
neurons: role of mitogen- and stress-activated kinase-1. J. Neurochem. 101, 697–
708. doi: 10.1111/j.1471-4159.2006.04352.x
Breese, G. R., Overstreet, D. H., Knapp, D. J., and Navarro, M. (2005). Prior
multiple ethanol withdrawals enhance stress-induced anxiety-like behavior:
inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-
Frontiers in Integrative Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 24 | 6
Zamora-Martinez and Edwards ERK signaling in drug dependence
receptor agonist. Neuropsychopharmacology 30, 1662–1669. doi: 10.1038/sj.npp.
1300706
Bruchas, M. R., and Chavkin, C. (2010). Kinase cascades and ligand-directed
signaling at the kappa opioid receptor. Psychopharmacology (Berl) 210, 137–147.
doi: 10.1007/s00213-010-1806-y
Bruchas, M. R., Xu, M., and Chavkin, C. (2008). Repeated swim stress induces
kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
Neuroreport 19, 1417–1422. doi: 10.1097/WNR.0b013e32830dd655
Cao, H., Gao, Y. J., Ren, W. H., Li, T. T., Duan, K. Z., Cui, Y. H., et al. (2009).
Activation of extracellular signal-regulated kinase in the anterior cingulate
cortex contributes to the induction and expression of affective pain. J. Neurosci.
29, 3307–3321. doi: 10.1523/JNEUROSCI.4300-08.2009
Chandler, L. J., Carpenter-Hyland, E., Hendricson, A. W., Maldve, R. E., Morrisett,
R. A., Zhou, F. C., et al. (2006). Structural and functional modifications in
glutamateric synapses following prolonged ethanol exposure. Alcohol. Clin. Exp.
Res. 30, 368–376. doi: 10.1111/j.1530-0277.2006.00041.x
Cheung, P., Allis, C. D., and Sassone-Corsi, P. (2000). Signaling to chro-
matin through histone modifications. Cell 103, 263–271. doi: 10.1016/s0092-
8674(00)00118-5
Ciccarelli, A., Calza, A., Santoru, F., Grasso, F., Concas, A., Sassoe-Pognetto,
M., et al. (2013). Morphine withdrawal produces ERK-dependent and ERK-
independent epigenetic marks in neurons of the nucleus accumbens and lat-
eral septum. Neuropharmacology 70, 168–179. doi: 10.1016/j.neuropharm.2012.
12.010
Corl, A. B., Berger, K. H., Ophir-Shohat, G., Gesch, J., Simms, J. A., Bartlett, S. E.,
et al. (2009). Happyhour, a Ste20 family kinase, implicates EGFR signaling in
ethanol-induced behaviors. Cell 137, 949–960. doi: 10.1016/j.cell.2009.03.020
Crews, F. T., Zou, J., and Qin, L. (2011). Induction of innate immune genes in brain
create the neurobiology of addiction. Brain Behav. Immun. 25(Suppl. 1), S4–S12.
doi: 10.1016/j.bbi.2011.03.003
Day, J. J., and Sweatt, J. D. (2011). Epigenetic mechanisms in cognition. Neuron 70,
813–829. doi: 10.1016/j.neuron.2011.05.019
De Witte, P., Pinto, E., Ansseau, M., and Verbanck, P. (2003). Alcohol and with-
drawal: from animal research to clinical issues. Neurosci. Biobehav. Rev. 27, 189–
197. doi: 10.1016/s0149-7634(03)00030-7
Eddison, M., Guarnieri, D. J., Cheng, L., Liu, C. H., Moffat, K. G., Davis, G., et al.
(2011). Arouser reveals a role for synapse number in the regulation of ethanol
sensitivity. Neuron 70, 979–990. doi: 10.1016/j.neuron.2011.03.030
Edwards, S., and Koob, G. F. (2010). Neurobiology of dysregulated motivational
systems in drug addiction. Future Neurol. 5, 393–401. doi: 10.2217/fnl.10.14
Edwards, S., and Koob, G. F. (2012). Experimental psychiatric illness and drug
abuse models: from human to animal, an overview. Methods Mol. Biol. 829, 31–
48. doi: 10.1007/978-1-61779-458-2_2
Edwards, S., and Koob, G. F. (2013). Escalation of drug self-administration as a
hallmark of persistent addiction liability. Behav. Pharmacol. 24, 356–362. doi: 10.
1097/FBP.0b013e3283644d15
Edwards, S., Bachtell, R. K., Guzman, D., Whisler, K. N., and Self, D. W. (2011).
Emergence of context-associated GluR(1) and ERK phosphorylation in the
nucleus accumbens core during withdrawal from cocaine self-administration.
Addict. Biol. 16, 450–457. doi: 10.1111/j.1369-1600.2010.00296.x
Edwards, S., Baynes, B. B., Carmichael, C. Y., Zamora-Martinez, E. R., Barrus, M.,
Koob, G. F., et al. (2013). Traumatic stress reactivity promotes excessive alcohol
drinking and alters the balance of prefrontal cortex-amygdala activity. Transl.
Psychiatry 3:e296. doi: 10.1038/tp.2013.70
Edwards, S., Graham, D. L., Whisler, K. N., and Self, D. W. (2009). Phosphorylation
of GluR1, ERK and CREB during spontaneous withdrawal from chronic heroin
self-administration. Synapse 63, 224–235. doi: 10.1002/syn.20601
Edwards, S., Guerrero, M., Ghoneim, O. M., Roberts, E., and Koob, G. F. (2012a).
Evidence that vasopressin V1b receptors mediate the transition to excessive
drinking in ethanol-dependent rats. Addict. Biol. 17, 76–85. doi: 10.1111/j.1369-
1600.2010.00291.x
Edwards, S., Vendruscolo, L. F., Schlosburg, J. E., Misra, K. K., Wee, S., Park,
P. E., et al. (2012b). Development of mechanical hypersensitivity in rats during
heroin and ethanol dependence: alleviation by CRF(1) receptor antagonism.
Neuropharmacology 62, 1142–1151. doi: 10.1016/j.neuropharm.2011.11.006
Eitan, S., Bryant, C. D., Saliminejad, N., Yang, Y. C., Vojdani, E., Keith, D. Jr.,
et al. (2003). Brain region-specific mechanisms for acute morphine-induced
mitogen-activated protein kinase modulation and distinct patterns of activation
during analgesic tolerance and locomotor sensitization. J. Neurosci. 23, 8360–
8369.
Einat, H., Yuan, P., Gould, T. D., Li, J., Du, J., Zhang, L., et al. (2003). The role of the
extracellular signal-regulated kinase signaling pathway in mood modulation. J.
Neurosci. 23, 7311–7316.
Engdahl, B., Dikel, T. N., Eberly, R., and Blank, A. Jr. (1998). Comorbidity and
course of psychiatric disorders in a community sample of former prisoners of
war. Am. J. Psychiatry 155, 1740–1745.
Faccidomo, S., Besheer, J., Stanford, P. C., and Hodge, C. W. (2009). Increased
operant responding for ethanol in male C57BL/6J mice: specific regulation by
the ERK1/2, but not JNK, MAP kinase pathway. Psychopharmacology (Berl) 204,
135–147. doi: 10.1007/s00213-008-1444-9
Ferrer-Alcón, M., Garcia-Fuster, M. J., La Harpe, R., and Garcia-Sevilla, J. A.
(2004a). Long-term regulation of signalling components of adenylyl cyclase
and mitogen-activated protein kinase in the pre-frontal cortex of human opiate
addicts. J. Neurochem. 90, 220–230. doi: 10.1111/j.1471-4159.2004.02473.x
Ferrer-Alcón, M., La Harpe, R., and Garcia-Sevilla, J. A. (2004b). Decreased
immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-
arrestin-2 in postmortem brains of opiate addicts. Brain Res. Mol. Brain Res. 121,
114–122. doi: 10.1016/j.molbrainres.2003.11.009
Fu, Y., Han, J., Ishola, T., Scerbo, M., Adwanikar, H., Ramsey, C., et al. (2008).
PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic
plasticity and behavior. Mol. Pain 4:26. doi: 10.1186/1744-8069-4-26
Funk, C. K., and Koob, G. F. (2007). A CRF(2) agonist administered into
the central nucleus of the amygdala decreases ethanol self-administration in
ethanol-dependent rats. Brain Res. 1155, 172–178. doi: 10.1016/j.brainres.2007.
04.009
Funk, C. K., Zorrilla, E. P., Lee, M. J., Rice, K. C., and Koob, G. F. (2007).
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-
administration in ethanol-dependent rats. Biol. Psychiatry 61, 78–86. doi: 10.
1016/j.biopsych.2006.03.063
Gholizadeh, S., Sun, N., De Jaeger, X., Bechard, M., Coolen, L., and Laviolette,
S. R. (2013). Early versus late-phase consolidation of opiate reward memo-
ries requires distinct molecular and temporal mechanisms in the amygdala-
prefrontal cortical pathway. PLoS One 8:e63612. doi: 10.1371/journal.pone.
0063612
Gianoulakis, C. (2009). Endogenous opioids and addiction to alcohol and
other drugs of abuse. Curr. Top. Med. Chem. 9, 999–1015. doi: 10.2174/
156802609789630956
Gilboa, A., Shalev, A. Y., Laor, L., Lester, H., Louzoun, Y., Chisin, R., et al.
(2004). Functional connectivity of the prefrontal cortex and the amygdala
in posttraumatic stress disorder. Biol. Psychiatry 55, 263–272. doi: 10.1016/j.
biopsych.2003.08.004
Gilpin, N. W., and Koob, G. F. (2008). Neurobiology of alcohol dependence: focus
on motivational mechanisms. Alcohol Res. Health 31, 185–195.
Gilpin, N. W., Richardson, H. N., Cole, M., and Koob, G. F. (2008). Vapor
inhalation of alcohol in rats. Curr. Protoc. Neurosci. Chapter 9, Unit 9.29. doi: 10.
1002/0471142301.ns0929s44
Girault, J. A., Valjent, E., Caboche, J., and Herve, D. (2007). ERK2: a logical
AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77–85.
doi: 10.1016/j.coph.2006.08.012
Grimm, J. W., Fyall, A. M., and Osincup, D. P. (2005). Incubation of sucrose craving:
effects of reduced training and sucrose pre-loading. Physiol. Behav. 84, 73–79.
doi: 10.1016/j.physbeh.2004.10.011
Grimm, J. W., Hope, B. T., Wise, R. A., and Shaham, Y. (2001). Neuroadaptation.
Incubation of cocaine craving after withdrawal. Nature 412, 141–142. doi: 10.
1038/35084134
Grimm, J. W., Shaham, Y., and Hope, B. T. (2002). Effect of cocaine and sucrose
withdrawal period on extinction behavior, cue-induced reinstatement and pro-
tein levels of the dopamine transporter and tyrosine hydroxylase in limbic and
cortical areas in rats. Behav. Pharmacol. 13, 379–388. doi: 10.1097/00008877-
200209000-00011
Hansson, A. C., Bermudez-Silva, F. J., Malinen, H., Hyytia, P., Sanchez-Vera, I.,
Rimondini, R., et al. (2007). Genetic impairment of frontocortical endocannabi-
noid degradation and high alcohol preference. Neuropsychopharmacology 32,
117–126. doi: 10.1038/sj.npp.1301034
Hansson, A. C., Rimondini, R., Neznanova, O., Sommer, W. H., and Heilig, M.
(2008). Neuroplasticity in brain reward circuitry following a history of ethanol
Frontiers in Integrative Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 24 | 7
Zamora-Martinez and Edwards ERK signaling in drug dependence
dependence. Eur. J. Neurosci. 27, 1912–1922. doi: 10.1111/j.1460-9568.2008.
06159.x
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares-Reyes, J. A., and Dautzenberg,
F. M. (2009). Role of CRF receptor signaling in stress vulnerability, anxiety and
depression. Ann. N Y Acad. Sci. 1179, 120–143. doi: 10.1111/j.1749-6632.2009.
05011.x
Heilig, M., and Koob, G. F. (2007). A key role for corticotropin-releasing factor
in alcohol dependence. Trends Neurosci. 30, 399–406. doi: 10.1016/j.tins.2007.
06.006
Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., and Stinus, L. (1995).
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive
consequences of morphine withdrawal. Behav. Pharmacol. 6, 74–80. doi: 10.
1097/00008877-199501000-00011
Herz, A. (1997). Endogenous opioid systems and alcohol addiction. Psychopharma-
cology (Berl) 129, 99–111. doi: 10.1007/s002130050169
Hofford, R. S., Hodgson, S. R., Roberts, K. W., Bryant, C. D., Evans, C. J., and Eitan,
S. (2009). Extracellular signal-regulated kinase activation in the amygdala medi-
ates elevated plus maze behavior during opioid withdrawal. Behav. Pharmacol.
20, 576–583. doi: 10.1097/FBP.0b013e32832ec57e
Holmes, A., Spanagel, R., and Krystal, J. H. (2013). Glutamatergic targets for
new alcohol medications. Psychopharmacology (Berl) 229, 539–554. doi: 10.
1007/s00213-013-3226-2
Huang, P. K., Aarde, S. M., Angrish, D., Houseknecht, K. L., Dickerson, T. J.,
and Taffe, M. A. (2012). Contrasting effects of d-methamphetamine, 3,4-
methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone and 4-
methylmethcathinone on wheel activity in rats. Drug Alcohol Depend. 126,
168–175. doi: 10.1016/j.drugalcdep.2012.05.011
Hyman, S. E. (2005). Addiction: a disease of learning and memory.Am. J. Psychiatry
162, 1414–1422. doi: 10.1176/appi.ajp.162.8.1414
Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006). Neural mechanisms of
addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci.
29, 565–598. doi: 10.1146/annurev.neuro.29.051605.113009
Ibba, F., Vinci, S., Spiga, S., Peana, A. T., Assaretti, A. R., Spina, L., et al. (2009).
Ethanol-induced extracellular signal regulated kinase: role of dopamine D1
receptors. Alcohol. Clin. Exp. Res. 33, 858–867. doi: 10.1111/j.1530-0277.2009.
00907.x
Jacobsen, L. K., Southwick, S. M., and Kosten, T. R. (2001). Substance use disorders
in patients with posttraumatic stress disorder: a review of the literature. Am. J.
Psychiatry 158, 1184–1190. doi: 10.1176/appi.ajp.158.8.1184
Kageyama, K., Hanada, K., Moriyama, T., Imaizumi, T., Satoh, K., and
Suda, T. (2007). Differential regulation of CREB and ERK phosphoryla-
tion through corticotropin-releasing factor receptors type 1 and 2 in AtT-20
and A7r5 cells. Mol. Cell. Endocrinol. 263, 90–102. doi: 10.1016/j.mce.2006.
08.011
Kalivas, P. W., and O’brien, C. (2008). Drug addiction as a pathology of staged
neuroplasticity. Neuropsychopharmacology 33, 166–180. doi: 10.1038/sj.npp.
1301564
Kalivas, P. W., and Volkow, N. D. (2005). The neural basis of addiction: a pathology
of motivation and choice. Am. J. Psychiatry 162, 1403–1413. doi: 10.1176/appi.
ajp.162.8.1403
Kelley, A. E. (2004). Memory and addiction: shared neural circuitry and molecular
mechanisms. Neuron 44, 161–179. doi: 10.1016/j.neuron.2004.09.016
Kelley, A. E., Bakshi, V. P., Haber, S. N., Steininger, T. L., Will, M. J., and Zhang,
M. (2002). Opioid modulation of taste hedonics within the ventral striatum.
Physiol. Behav. 76, 365–377. doi: 10.1016/s0031-9384(02)00751-5
Kelley, A. E., Schiltz, C. A., and Landry, C. F. (2005). Neural systems recruited by
drug- and food-related cues: studies of gene activation in corticolimbic regions.
Physiol. Behav. 86, 11–14. doi: 10.1016/j.physbeh.2005.06.018
Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A., and Koob, G. F.
(2006). Conditioned withdrawal drives heroin consumption and decreases
reward sensitivity. J. Neurosci. 26, 5894–5900. doi: 10.1523/jneurosci.0740-06.
2006
Koob, G. F., and Bloom, F. E. (1988). Cellular and molecular mechanisms of drug
dependence. Science 242, 715–723. doi: 10.1126/science.2903550
Koob, G. F., and Le Moal, M. (1997). Drug abuse: hedonic homeostatic dysregula-
tion. Science 278, 52–58. doi: 10.1126/science.278.5335.52
Koob, G. F., and Le Moal, M. (2008). Addiction and the brain antireward system.
Annu. Rev. Psychol. 59, 29–53. doi: 10.1146/annurev.psych.59.103006.093548
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., et al.
(2014). Addiction as a stress surfeit disorder. Neuropharmacology 76, 370–382.
doi: 10.1016/j.neuropharm.2013.05.024
Koob, G. F., Roberts, A. J., Kieffer, B. L., Heyser, C. J., Katner, S. N., Ciccocioppo,
R., et al. (2003). Animal models of motivation for drinking in rodents with a
focus on opioid receptor neuropharmacology. Recent Dev. Alcohol. 16, 263–281.
doi: 10.1007/0-306-47939-7_19
Lack, A. K., Floyd, D. W., and Mccool, B. A. (2005). Chronic ethanol ingestion
modulates proanxiety factors expressed in rat central amygdala. Alcohol 36, 83–
90. doi: 10.1016/j.alcohol.2005.07.004
Li, T., Hou, Y., Cao, W., Yan, C. X., Chen, T., and Li, S. B. (2010). Naloxone-
precipitated withdrawal enhances ERK phosphorylation in prefrontal associa-
tion cortex and accumbens nucleus of morphine-dependent mice.Neurosci. Lett.
468, 348–352. doi: 10.1016/j.neulet.2009.11.030
Li, Y. Q., Li, F. Q., Wang, X. Y., Wu, P., Zhao, M., Xu, C. M., et al. (2008).
Central amygdala extracellular signal-regulated kinase signaling pathway is
critical to incubation of opiate craving. J. Neurosci. 28, 13248–13257. doi: 10.
1523/JNEUROSCI.3027-08.2008
Li, F., Wang, X. S., Dai, R. P., Zhang, J. Y., Zhou, X. F., Hao, W., et al. (2011).
The activation of NMDA receptor-ERK pathway in the central amygdala is
required for the expression of morphine-conditioned place preference in the rat.
Neurotox. Res. 20, 362–371. doi: 10.1007/s12640-011-9250-2
Liu, Y. L., Yan, L. D., Zhou, P. L., Wu, C. F., and Gong, Z. H. (2009). Levo-
tetrahydropalmatine attenuates oxycodone-induced conditioned place prefer-
ence in rats. Eur. J. Pharmacol. 602, 321–327. doi: 10.1016/j.ejphar.2008.11.031
Lu, L., Koya, E., Zhai, H., Hope, B. T., and Shaham, Y. (2006). Role of ERK in
cocaine addiction. Trends Neurosci. 29, 695–703. doi: 10.1016/j.tins.2006.10.005
Lyons, D., De Jaeger, X., Rosen, L. G., Ahmad, T., Lauzon, N. M., Zunder, J., et al.
(2013). Opiate exposure and withdrawal induces a molecular memory switch
in the basolateral amygdala between ERK1/2 and CaMKIIalpha-dependent
signaling substrates. J. Neurosci. 33, 14693–14704. doi: 10.1523/JNEUROSCI.
1226-13.2013
Macey, T. A., Lowe, J. D., and Chavkin, C. (2006). Mu opioid receptor activation of
ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J. Biol. Chem. 281,
34515–34524. doi: 10.1074/jbc.m604278200
Mason, B. J., Shaham, Y., Weiss, F., and Le, A. D. (2009). Stress, alcohol craving
and relapse risk: mechanisms and viable treatment targets. Alcohol 43, 541–543.
doi: 10.1016/j.alcohol.2009.09.024
Maze, I., and Nestler, E. J. (2011). The epigenetic landscape of addiction. Ann. N Y
Acad. Sci. 1216, 99–113. doi: 10.1111/j.1749-6632.2010.05893.x
Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W.,
et al. (2002). Knockout of ERK1 MAP kinase enhances synaptic plasticity in
the striatum and facilitates striatal-mediated learning and memory. Neuron 34,
807–820. doi: 10.1016/s0896-6273(02)00716-x
McNally, G. P., and Akil, H. (2002). Role of corticotropin-releasing hormone in
the amygdala and bed nucleus of the stria terminalis in the behavioral, pain
modulatory and endocrine consequences of opiate withdrawal. Neuroscience
112, 605–617. doi: 10.1016/s0306-4522(02)00105-7
Melis, M., Enrico, P., Peana, A. T., and Diana, M. (2007). Acetaldehyde mediates
alcohol activation of the mesolimbic dopamine system. Eur. J. Neurosci. 26,
2824–2833. doi: 10.1111/j.1460-9568.2007.05887.x
Meng, Q. Y., Chen, X. N., Tong, D. L., and Zhou, J. N. (2011). Stress and
glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex.
Mol. Cell. Endocrinol. 342, 54–63. doi: 10.1016/j.mce.2011.05.035
Moron, J. A., Gullapalli, S., Taylor, C., Gupta, A., Gomes, I., and Devi,
L. A. (2010). Modulation of opiate-related signaling molecules in morphine-
dependent conditioned behavior: conditioned place preference to morphine
induces CREB phosphorylation. Neuropsychopharmacology 35, 955–966. doi: 10.
1038/npp.2009.199
Muller, D. L., and Unterwald, E. M. (2004). In vivo regulation of extracellular
signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphory-
lation by acute and chronic morphine. J. Pharmacol. Exp. Ther. 310, 774–782.
doi: 10.1124/jpet.104.066548
National Institute on Alcohol Abuse and Alcoholism. (2010). Beyond hangovers:
understanding alcohol’s impact on your health. NIH Publication No. 13-7604.
http://pubs.niaaa.nih.gov/publications/Hangovers/beyondHangovers.htm
Neisewander, J. L., Baker, D. A., Fuchs, R. A., Tran-Nguyen, L. T., Palmer, A., and
Marshall, J. F. (2000). Fos protein expression and cocaine-seeking behavior in
Frontiers in Integrative Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 24 | 8
Zamora-Martinez and Edwards ERK signaling in drug dependence
rats after exposure to a cocaine self-administration environment. J. Neurosci. 20,
798–805.
Nestler, E. J. (2005). Is there a common molecular pathway for addiction? Nat.
Neurosci. 8, 1445–1449. doi: 10.1038/nn1578
O’Brien, C. P. (1997). A range of research-based pharmacotherapies for addiction.
Science 278, 66–70. doi: 10.1126/science.278.5335.66
O’Dell, L. E., Roberts, A. J., Smith, R. T., and Koob, G. F. (2004). Enhanced alcohol
self-administration after intermittent versus continuous alcohol vapor exposure.
Alcohol. Clin. Exp. Res. 28, 1676–1682. doi: 10.1097/01.alc.0000145781.11923.4e
Ortiz, J., Harris, H. W., Guitart, X., Terwilliger, R. Z., Haycock, J. W., and Nestler,
E. J. (1995). Extracellular signal-regulated protein kinases (ERKs) and ERK
kinase (MEK) in brain: regional distribution and regulation by chronic mor-
phine. J. Neurosci. 15, 1285–1297.
Pandey, S. C., Roy, A., and Zhang, H. (2003). The decreased phosphorylation of
cyclic adenosine monophosphate (cAMP) response element binding (CREB)
protein in the central amygdala acts as a molecular substrate for anxiety related
to ethanol withdrawal in rats. Alcohol. Clin. Exp. Res. 27, 396–409. doi: 10.
1097/01.alc.0000056616.81971.49
Pandey, S. C., Roy, A., Zhang, H., and Xu, T. (2004). Partial deletion of the cAMP
response element-binding protein gene promotes alcohol-drinking behaviors. J.
Neurosci. 24, 5022–5030. doi: 10.1523/jneurosci.5557-03.2004
Pandey, S. C., Zhang, H., Roy, A., and Misra, K. (2006). Central and medial
amygdaloid brain-derived neurotrophic factor signaling plays a critical role in
alcohol-drinking and anxiety-like behaviors. J. Neurosci. 26, 8320–8331. doi: 10.
1523/jneurosci.4988-05.2006
Pandey, S. C., Zhang, H., Roy, A., and Xu, T. (2005). Deficits in amygdaloid
cAMP-responsive element-binding protein signaling play a role in genetic
predisposition to anxiety and alcoholism. J. Clin. Invest. 115, 2762–2773. doi: 10.
1172/jci24381
Pandey, S. C., Zhang, H., Ugale, R., Prakash, A., Xu, T., and Misra, K. (2008).
Effector immediate-early gene arc in the amygdala plays a critical role in
alcoholism. J. Neurosci. 28, 2589–2600. doi: 10.1523/JNEUROSCI.4752-07.2008
Payne, D. M., Rossomando, A. J., Martino, P., Erickson, A. K., Her, J. H.,
Shabanowitz, J., et al. (1991). Identification of the regulatory phosphorylation
sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10,
885–892.
Peng, J., Wagle, M., Mueller, T., Mathur, P., Lockwood, B. L., Bretaud, S., et al.
(2009). Ethanol-modulated camouflage response screen in zebrafish uncov-
ers a novel role for cAMP and extracellular signal-regulated kinase signal-
ing in behavioral sensitivity to ethanol. J. Neurosci. 29, 8408–8418. doi: 10.
1523/JNEUROSCI.0714-09.2009
Philibin, S. D., Hernandez, A., Self, D. W., and Bibb, J. A. (2011). Striatal signal
transduction and drug addiction. Front. Neuroanat. 5:60. doi: 10.3389/fnana.
2011.00060
Potenza, M. N. (2014). Obesity, food and addiction: emerging neuroscience and
clinical and public health implications. Neuropsychopharmacology 39, 249–250.
doi: 10.1038/npp.2013.198
Potter, D. N., Damez-Werno, D., Carlezon, W. A. Jr., Cohen, B. M., and Chartoff,
E. H. (2011). Repeated exposure to the kappa-opioid receptor agonist salvinorin
A modulates extracellular signal-regulated kinase and reward sensitivity. Biol.
Psychiatry 70, 744–753. doi: 10.1016/j.biopsych.2011.05.021
Punn, A., Levine, M. A., and Grammatopoulos, D. K. (2006). Identification
of signaling molecules mediating corticotropin-releasing hormone-R1alpha-
mitogen-activated protein kinase (MAPK) interactions: the critical role of phos-
phatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.
Mol. Endocrinol. 20, 3179–3195. doi: 10.1210/me.2006-0255
Quertemont, E., Green, H. L., and Grant, K. A. (2003). Brain ethanol concentra-
tions and ethanol discrimination in rats: effects of dose and time. Psychophar-
macology (Berl) 168, 262–270. doi: 10.1007/s00213-003-1437-7
Radwanska, K., Wrobel, E., Korkosz, A., Rogowski, A., Kostowski, W., Bienkowski,
P., et al. (2008). Alcohol relapse induced by discrete cues activates components
of AP-1 transcription factor and ERK pathway in the rat basolateral and cen-
tral amygdala. Neuropsychopharmacology 33, 1835–1846. doi: 10.1038/sj.npp.
1301567
Refojo, D., Echenique, C., Muller, M. B., Reul, J. M., Deussing, J. M., Wurst, W., et al.
(2005). Corticotropin-releasing hormone activates ERK1/2 MAPK in specific
brain areas. Proc. Natl. Acad. Sci. U S A 102, 6183–6188. doi: 10.1073/pnas.
0502070102
Rimondini, R., Arlinde, C., Sommer, W., and Heilig, M. (2002). Long-lasting
increase in voluntary ethanol consumption and transcriptional regulation in
the rat brain after intermittent exposure to alcohol. FASEB J. 16, 27–35. doi: 10.
1096/fj.01-0593com
Robbins, D. J., Zhen, E., Owaki, H., Vanderbilt, C. A., Ebert, D., Geppert, T. D.,
et al. (1993). Regulation and properties of extracellular signal-regulated protein
kinases 1 and 2 in vitro. J. Biol. Chem. 268, 5097–5106.
Roberto, M., Bajo, M., Crawford, E., Madamba, S. G., and Siggins, G. R. (2006).
Chronic ethanol exposure and protracted abstinence alter NMDA receptors in
central amygdala. Neuropsychopharmacology 31, 988–996. doi: 10.1038/sj.npp.
1300840
Roberts, A. J., Cole, M., and Koob, G. F. (1996). Intra-amygdala muscimol decreases
operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res.
20, 1289–1298. doi: 10.1111/j.1530-0277.1996.tb01125.x
Roberto, M., Nelson, T. E., Ur, C. L., Brunelli, M., Sanna, P. P., and Gruol, D. L.
(2003). The transient depression of hippocampal CA1 LTP induced by chronic
intermittent ethanol exposure is associated with an inhibition of the MAP
kinase pathway. Eur. J. Neurosci. 17, 1646–1654. doi: 10.1046/j.1460-9568.2003.
02614.x
Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., and
Siggins, G. R. (2004). Acute and chronic ethanol alter glutamatergic transmis-
sion in rat central amygdala: an in vitro and in vivo analysis. J. Neurosci. 24,
1594–1603. doi: 10.1523/jneurosci.5077-03.2004
Roberts, A. J., Heyser, C. J., Cole, M., Griffin, P., and Koob, G. F. (2000).
Excessive ethanol drinking following a history of dependence: animal model of
allostasis. Neuropsychopharmacology 22, 581–594. doi: 10.1016/s0893-133x(99)
00167-0
Robison, A. J., and Nestler, E. J. (2011). Transcriptional and epigenetic mechanisms
of addiction. Nat. Rev. Neurosci. 12, 623–637. doi: 10.1038/nrn3111
Ron, D. (2004). Signaling cascades regulating NMDA receptor sensitivity to
ethanol. Neuroscientist 10, 325–336. doi: 10.1177/1073858404263516
Ron, D., and Messing, R. O. (2013). Signaling pathways mediating alcohol
effects. Curr. Top. Behav. Neurosci. 13, 87–126. doi: 10.1007/978-3-642-28720-
6_161
Ruggeri, B., Braconi, S., Cannella, N., Kallupi, M., Soverchia, L., Ciccocioppo, R.,
et al. (2010). Neuropeptide S receptor gene expression in alcohol withdrawal and
protracted abstinence in postdependent rats. Alcohol. Clin. Exp. Res. 34, 90–97.
doi: 10.1111/j.1530-0277.2009.01070.x
Sananbenesi, F., Fischer, A., Schrick, C., Spiess, J., and Radulovic, J. (2003).
Mitogen-activated protein kinase signaling in the hippocampus and its modu-
lation by corticotropin-releasing factor receptor 2: a possible link between stress
and fear memory. J. Neurosci. 23, 11436–11443.
Sanna, P. P., Simpson, C., Lutjens, R., and Koob, G. (2002). ERK regulation in
chronic ethanol exposure and withdrawal. Brain Res. 948, 186–191. doi: 10.
1016/s0006-8993(02)03191-8
Schlosburg, J. E., Whitfield, T. W. Jr., Park, P. E., Crawford, E. F., George,
O., Vendruscolo, L. F., et al. (2013). Long-term antagonism of kappa opi-
oid receptors prevents escalation of and increased motivation for heroin
intake. J. Neurosci. 33, 19384–19392. doi: 10.1523/JNEUROSCI.1979-13.
2013
Schroeder, J. P., Spanos, M., Stevenson, J. R., Besheer, J., Salling, M., and Hodge,
C. W. (2008). Cue-induced reinstatement of alcohol-seeking behavior is asso-
ciated with increased ERK1/2 phosphorylation in specific limbic brain regions:
blockade by the mGluR5 antagonist MPEP. Neuropharmacology 55, 546–554.
doi: 10.1016/j.neuropharm.2008.06.057
Seal, K. H., Shi, Y., Cohen, G., Cohen, B. E., Maguen, S., Krebs, E. E., et al. (2012).
Association of mental health disorders with prescription opioids and high-risk
opioid use in US veterans of Iraq and Afghanistan. JAMA 307, 940–947. doi: 10.
1001/jama.2012.5573
Self, D. W., and Nestler, E. J. (1998). Relapse to drug-seeking: neural and
molecular mechanisms. Drug Alcohol Depend. 51, 49–60. doi: 10.1016/s0376-
8716(98)00065-9
Shalev, U., Morales, M., Hope, B., Yap, J., and Shaham, Y. (2001). Time-dependent
changes in extinction behavior and stress-induced reinstatement of drug seeking
following withdrawal from heroin in rats. Psychopharmacology (Berl) 156, 98–
107. doi: 10.1007/s002130100748
Shaw-Lutchman, T. Z., Barrot, M., Wallace, T., Gilden, L., Zachariou, V., Impey,
S., et al. (2002). Regional and cellular mapping of cAMP response element-
Frontiers in Integrative Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 24 | 9
Zamora-Martinez and Edwards ERK signaling in drug dependence
mediated transcription during naltrexone-precipitated morphine withdrawal. J.
Neurosci. 22, 3663–3672.
Shekhar, A., Truitt, W., Rainnie, D., and Sajdyk, T. (2005). Role of stress, corti-
cotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.
Stress 8, 209–219. doi: 10.1080/10253890500504557
Shurman, J., Koob, G. F., and Gutstein, H. B. (2010). Opioids, pain, the brain and
hyperkatifeia: a framework for the rational use of opioids for pain. PainMed. 11,
1092–1098. doi: 10.1111/j.1526-4637.2010.00881.x
Siggins, G. R., Martin, G., Roberto, M., Nie, Z., Madamba, S., and De Lecea, L.
(2003). Glutamatergic transmission in opiate and alcohol dependence. Ann. N Y
Acad. Sci. 1003, 196–211. doi: 10.1196/annals.1300.012
Sinclair, C. M., Cleva, R. M., Hood, L. E., Olive, M. F., and Gass, J. T. (2012).
mGluR5 receptors in the basolateral amygdala and nucleus accumbens regulate
cue-induced reinstatement of ethanol-seeking behavior. Pharmacol. Biochem.
Behav. 101, 329–335. doi: 10.1016/j.pbb.2012.01.014
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R.,
Barr, C. S., et al. (2008). Upregulation of voluntary alcohol intake, behav-
ioral sensitivity to stress and amygdala crhr1 expression following a history
of dependence. Biol. Psychiatry 63, 139–145. doi: 10.1016/j.biopsych.2007.
01.010
Stacey, D., Bilbao, A., Maroteaux, M., Jia, T., Easton, A. C., Longueville, S.,
et al. (2012). RASGRF2 regulates alcohol-induced reinforcement by influencing
mesolimbic dopamine neuron activity and dopamine release. Proc. Natl. Acad.
Sci. U S A 109, 21128–21133. doi: 10.1073/pnas.1211844110
Stinus, L., Caille, S., and Koob, G. F. (2000). Opiate withdrawal-induced place
aversion lasts for up to 16 weeks. Psychopharmacology (Berl) 149, 115–120.
doi: 10.1007/s002139900358
Substance Abuse and Mental Health Services Administration. (2008). Results from
the 2007 National Survey on Drug Use and Health: National Findings, MD, USA:
Office of Applied Statistics.
Szumlinski, K. K., Diab, M. E., Friedman, R., Henze, L. M., Lominac, K. D.,
and Bowers, M. S. (2007). Accumbens neurochemical adaptations produced
by binge-like alcohol consumption. Psychopharmacology (Berl) 190, 415–431.
doi: 10.1007/s00213-006-0641-7
Thorsell, A., Tapocik, J. D., Liu, K., Zook, M., Bell, L., Flanigan, M., et al. (2013).
A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks
alcohol-induced ERK-phosphorylation in the central amygdala and decreases
operant alcohol self-administration in rats. J. Neurosci. 33, 10132–10142. doi: 10.
1523/JNEUROSCI.4742-12.2013
Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M., Stalla, G. K., et al. (1998).
Impaired stress response and reduced anxiety in mice lacking a functional
corticotropin-releasing hormone receptor 1. Nat. Genet. 19, 162–166. doi: 10.
1038/520
Ting, A. K. R., and Van Der Kooy, D. (2012). The neurobiology of opiate moti-
vation. Cold Spring Harb. Perspect. Med. 2:a012096. doi: 10.1101/cshperspect.
a012096
Torres, O. V., Walker, E. M., Beas, B. S., and O’dell, L. E. (2013). Female rats display
enhanced rewarding effects of ethanol that are hormone dependent. Alcohol.
Clin. Exp. Res. 38, 108–115. doi: 10.1111/acer.12213
Trigo, J. M., Martin-Garcia, E., Berrendero, F., Robledo, P., and Maldonado,
R. (2010). The endogenous opioid system: a common substrate in drug
addiction. Drug Alcohol Depend. 108, 183–194. doi: 10.1016/j.drugalcdep.2009.
10.011
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P.,
et al. (2002). Increased ethanol self-administration and anxiety-like behavior
during acute ethanol withdrawal and protracted abstinence: regulation by
corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 26, 1494–1501. doi: 10.
1111/j.1530-0277.2002.tb02448.x
Valjent, E., Pages, C., Herve, D., Girault, J. A., and Caboche, J. (2004). Addictive
and non-addictive drugs induce distinct and specific patterns of ERK activation
in mouse brain. Eur. J. Neurosci. 19, 1826–1836. doi: 10.1111/j.1460-9568.2004.
03278.x
Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J. C.,
et al. (2005). Regulation of a protein phosphatase cascade allows convergent
dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl.
Acad. Sci. U S A 102, 491–496. doi: 10.1073/pnas.0408305102
Vendruscolo, L. F., Schlosburg, J. E., Misra, K. K., Chen, S. A., Greenwell,
T. N., and Koob, G. F. (2011). Escalation patterns of varying periods of
heroin access. Pharmacol. Biochem. Behav. 98, 570–574. doi: 10.1016/j.pbb.2011.
03.004
Volkow, N. D., Wang, G. J., Tomasi, D., and Baler, R. D. (2013). Obesity and
addiction: neurobiological overlaps. Obes. Rev. 14, 2–18. doi: 10.1111/j.1467-
789X.2012.01031.x
Wagle, M., Mathur, P., and Guo, S. (2011). Corticotropin-releasing factor critical
for zebrafish camouflage behavior is regulated by light and sensitive to ethanol.
J. Neurosci. 31, 214–224. doi: 10.1523/JNEUROSCI.3339-10.2011
Walker, B. M., Valdez, G. R., Mclaughlin, J. P., and Bakalkin, G. (2012). Targeting
dynorphin/kappa opioid receptor systems to treat alcohol abuse and depen-
dence. Alcohol 46, 359–370. doi: 10.1016/j.alcohol.2011.10.006
Wang, W. S., Kang, S., Liu, W. T., Li, M., Liu, Y., Yu, C., et al. (2012). Extinction
of aversive memories associated with morphine withdrawal requires ERK-
mediated epigenetic regulation of brain-derived neurotrophic factor transcrip-
tion in the rat ventromedial prefrontal cortex. J. Neurosci. 32, 13763–13775.
doi: 10.1523/JNEUROSCI.1991-12.2012
West, R., and Gossop, M. (1994). Overview: a comparison of withdrawal symptoms
from different drug classes. Addiction 89, 1483–1489. doi: 10.1111/j.1360-0443.
1994.tb03747.x
Xu, Y., Lv, X. F., Cui, C. L., Ge, F. F., Li, Y. J., and Zhang, H. L. (2012). Essential role
of NR2B-containing NMDA receptor-ERK pathway in nucleus accumbens shell
in morphine-associated contextual memory. Brain Res. Bull. 89, 22–30. doi: 10.
1016/j.brainresbull.2012.06.012
Zhang, L. L., Wang, J. J., Liu, Y., Lu, X. B., Kuang, Y., Wan, Y. H., et al. (2011).
GPR26-deficient mice display increased anxiety- and depression-like behav-
iors accompanied by reduced phosphorylated cyclic AMP responsive element-
binding protein level in central amygdala. Neuroscience 196, 203–214. doi: 10.
1016/j.neuroscience.2011.08.069
Zhou, L., Lovell, K. M., Frankowski, K. J., Slauson, S. R., Phillips, A. M., Streicher,
J. M., et al. (2013). Development of functionally selective, small molecule
agonists at kappa opioid receptors. J. Biol. Chem. 288, 36703–36716. doi: 10.
1074/jbc.m113.504381
Zhu, Y., Wang, Y., Zhao, B., Wei, S., Xu, M., Liu, E., et al. (2013). Differential
phosphorylation of GluN1-MAPKs in rat brain reward circuits following long-
term alcohol exposure. PLoS One 8:e54930. doi: 10.1371/journal.pone.0054930
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 02 January 2014; accepted: 19 February 2014; published online: 11 March
2014.
Citation: Zamora-Martinez ER and Edwards S (2014) Neuronal extracellular signal-
regulated kinase (ERK) activity as marker and mediator of alcohol and opioid
dependence. Front. Integr. Neurosci. 8:24. doi: 10.3389/fnint.2014.00024
This article was submitted to the journal Frontiers in Integrative Neuroscience.
Copyright © 2014 Zamora-Martinez and Edwards. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Integrative Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 24 | 10
